DNA Methylation Market Size, Growth, Share, Trends and Forecast 2023 to 2028

According to the latest report by IMARC Group “DNA Methylation Market: Global Industry Size, Share, Trends, Growth Rate, Research Report, Opportunity and Forecast 2023-2028“. The global DNA methylation market size reached US$ 1.30 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.93 Billion by 2028, exhibiting a growth rate (CAGR) of 14.60% during 2023-2028. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the market in any form.

Deoxyribonucleic acid (DNA) methylation refers to an epigenetic mechanism that is used by cells to control gene expression. It relies on various technologies, such as polymerase chain reaction (PCR), microarray, and sequencing, that assist scientists in gaining valuable insights into gene regulation and potential biomarker identification. It is widely utilized in several processes, such as genomic imprinting and repression of repetitive element transcription and transposition. As a result, DNA methylation finds applications in hospitals, diagnostic centers, research and academic institution, and pharmaceutical and biotechnology companies across the globe.

Request for a free sample copy of this report: https://www.imarcgroup.com/dna-methylation-market/requestsample

DNA Methylation Market Trends:

Presently, the rising prevalence of various cancers among the masses worldwide represents one of the primary factors supporting the growth of the market. Additionally, the increasing awareness among individuals about diseases is strengthening the growth of the market. Apart from this, governing agencies of various countries are encouraging research and development (R&D) activities by offering funding, which is positively influencing the market. Moreover, the increasing product approvals and reduced cost of treatment are offering lucrative growth opportunities to industry investors. Furthermore, the rising adoption of epigenetics-based treatment techniques, along with the commercialization of nucleic acid-based diagnostic tests and kits across the globe, is contributing to the growth of the market.

Report Segmentation:

The report has segmented the market into the following categories:

Product Insights:

Consumables
Kits and Reagents
Enzymes
Instrument and Software

Technology Insights:

Polymerase Chain Reaction (PCR)
Microarray
Sequencing
Others

Application Insights:

Gene Therapy
Clinical Research
Diagnostics
Others

End User Insights:

Hospital and Diagnostic Laboratories
Pharmaceutical and Biotechnology Companies
Research and Academia

Market Breakup by Region:

North America (United States, Canada)
Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa

Competitive Landscape:

Abcam plc.
Active Motif Inc.
Diagenode S.A. (Hologic Inc.)
EpiGentek Group Inc.
Illumina Inc.
Merck KGaA
New England Biolabs Inc.
PerkinElmer Inc., Qiagen N.V.
Thermo-Fisher Scientific Inc.
Zymo Research Corporation

Ask Analyst for Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=6890&flag=C

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

Email: [email protected]

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Address: 134 N 4th St. Brooklyn, NY 11249, USA

Website: https://www.imarcgroup.com/

Follow us on Twitter: @imarcglobal

Linkedin: https://www.linkedin.com/company/imarc-group